Announcement • Dec 29
YourWay Cannabis Brands Inc., Annual General Meeting, Apr 11, 2024 YourWay Cannabis Brands Inc., Annual General Meeting, Apr 11, 2024. Announcement • Oct 19
YourWay Cannabis Brands Inc., Annual General Meeting, Dec 15, 2023 YourWay Cannabis Brands Inc., Annual General Meeting, Dec 15, 2023, at 13:00 US Eastern Standard Time. Announcement • Oct 18
YourWay Cannabis Brands Inc. Announces Resignation of Cohen as President of Arizona Operations YourWay Cannabis Brands Inc. announced, that in mutual agreement with Jacob Cohen, Mr. Cohen will resign from his position as President of Arizona operations of YourWay, effective immediately. Mr. Cohen will continue to serve as a member of the Company's board of directors. Mr. Cohen's contributions to the Company during his tenure have been acknowledged and appreciated. YourWay wishes him the best in his future endeavors. Announcement • Oct 07
YourWay Cannabis Brands Announces Complaint Against the Company YourWay Cannabis Brands Inc. announced the receipt of a complaint against the Company. Trulieve Cannabis Corp., Harvest Health & Recreation Inc., and Randy Taylor Consulting, LLC (collectively, the "Plaintiffs") filed a verified complaint in the Arizona Superior Court, Maricopa County, against, among others, the Company, Labtronix Inc., d/b/a Venom Extracts and YourWay Cottonwood, LLC (collectively, the "Defendants"). The Plaintiffs claim that the Defendants, their related entities and employees, participated in unlawful kickback schemes to the detriment of the Plaintiffs. While the Company has not yet filed a response to the complaint, the Company's current management team is working to investigate the claims as the alleged misconduct occurred prior to the tenure of the current management team. YourWay does not currently make any payments of the type alleged in the complaint. Once the Company's board of directors has authorized a proposed course of action, the Company will provide stakeholders with a further update. Announcement • Sep 13
YourWay Cannabis Brands Inc. Announces Executive Changes YourWay Cannabis Brands Inc. announced Jacob Cohen has resigned as Chief Executive Officer of YourWay effective immediately. Mr. Cohen will continue to serve as President of Arizona Operations and as a director on the Company's board of directors (the "Board"). The Company's Executive Chairman, Jakob Ripshtein, will assume the position of Acting Chief Executive Officer, effective immediately. Mr. Ripshtein was appointed as Chairman of the Board in 2021 and as Executive Chairman earlier this year. He previously served as the President of Aphria Inc., which was acquired by Tilray Brands Inc., where he was responsible for corporate strategy, marketing, and sales. Mr. Ripshtein holds a Bachelor of Business Administration from York University, as well as a CPA and International Tax designation. Mr. Ripshtein is currently CEO of Perennial Brands Inc., a full life-cycle brand strategy organization. In addition, the Board resolved to demand repayment of all amounts advanced to Ionic Brands Corp. ("Ionic") pursuant to a demand promissory note dated May 20, 2022. Announcement • Jun 30
YourWay Cannabis Brands Inc., Annual General Meeting, Aug 08, 2022 YourWay Cannabis Brands Inc., Annual General Meeting, Aug 08, 2022, at 13:00 Eastern Standard Time. Agenda: to receive and consider the audited consolidated financial statements of the Corporation for the financial year ended December 31, 2021 and the report of the auditor thereon (the "Annual Financial Statements"); to elect the directors of the Corporation for the ensuing year; to appoint Macias Gini & O'Connell LLP, Chartered Professional Accountants as auditor of the Corporation for the ensuing year and to authorize the directors to fix their remuneration; to consider and, if thought advisable, approve, with or without variation, an ordinary resolution approving the adoption of the Corporation's long term incentive plan and all unallocated awards issuable thereunder, as more fully described in the accompanying management information circular of the Corporation dated June 29, 2022 (the "Circular"); and to transact such other business as may properly come before the Meeting or any adjournment or postponement thereof. Board Change • Apr 27
High number of new and inexperienced directors There are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. No experienced directors. No highly experienced directors. Executive Chairman of the Board Jakob Ripshtein is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Announcement • Apr 23
YourWay Cannabis Brands Inc., Annual General Meeting, Jun 30, 2022 YourWay Cannabis Brands Inc., Annual General Meeting, Jun 30, 2022. Announcement • Mar 30
YourWay Cannabis Brands Inc. Appoints Sandra Ceccacci as CFO, Effective April 4, 2022 YourWay Cannabis Brands Inc. announced that Sandra Ceccacci, will join YourWay as its Chief Financial Officer effective April 4, 2022. Ms. Ceccacci joins YourWay from Clearway Group of Companies, where she served as Vice-President of Finance, providing strategic, operational, and financial leadership to one of Canada's leading nationwide contractors. Reported Earnings • Dec 01
Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations Third quarter 2021 results: EPS: US$0.002 (up from US$0.003 loss in 3Q 2020). Revenue: US$14.5m (up 53% from 3Q 2020). Net income: US$480.0k (up US$1.13m from 3Q 2020). Profit margin: 3.3% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Board Change • Nov 03
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. Independent Non-Executive Chairman Jakob Ripshtein is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Aug 26
Second quarter 2021 earnings released: EPS US$0.007 (vs US$0.003 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: US$17.6m (up 108% from 2Q 2020). Net income: US$1.88m (up US$1.57m from 2Q 2020). Profit margin: 11% (up from 3.6% in 2Q 2020). The increase in margin was driven by higher revenue. Reported Earnings • May 30
Full year 2020 earnings released: US$0.02 loss per share (vs US$0.068 loss in FY 2019) The company reported a solid full year result with improved revenues and control over costs, although losses increased. Full year 2020 results: Revenue: US$30.6m (up US$29.6m from FY 2019). Net loss: US$3.57m (loss widened 89% from FY 2019). Announcement • May 18
Hollister Biosciences Inc. and Heavy Grass Collaborate with Slipknot Co-Founder Shawn Clown Crahan on New HashBone Line Hollister Biosciences Inc. and Heavy Grass have partnered with Slipknot co-founder Shawn Clown Crahan for special-edition HashBone packs featuring six half-gram pre-rolls and matches in a soft-touch matte black case. The multi-platinum, Grammy-winning artist has sold more than 30 million records with Slipknot, whose last three albums debuted at No. 1 on both the Billboard 200 and the U.K. Albums Chart. Branded with original artwork, Clown's signature HashBone line contains a potent uplifting blend of 75% indica flower and 25% Paradise Citrus bubble hash. The signature premium indica flower features an earthy citrus-rich flavor profile with sublime sedating effects. Paraadise Citrus, made from crossing Tropicana Cookies and Tina, adds another layer of full-body relaxation with happy head highs and citrusy notes of orchard-fresh sour orange. Lab testing confirms the potency of these hash-infused pre-rolls with THC levels above 40%. Shawn Clown Crahan is a multi-talented artist who co-founded Slipknot, directed most of its music videos and serves as one of the primary songwriters. Clown is also the creative force behind Slipknot's iconic visuals, originating the masks and uniforms, creating album covers, packaging, live staging and visuals, and all merchandise. Announcement • Mar 03
Hollister Biosciences Inc. announced that it has received CAD 7.896809 million in funding On March 2, 2021, Hollister Biosciences Inc. (CNSX:HOLL) closed the transaction. The company issued 21,635,094 special warrants for gross proceeds of CAD 7,896,809.31 including 3,825,094 Special Warrants sold pursuant to the exercise in full of the agents' option granted to the agents. Each warrant will entitle the holder thereof to acquire one Share at a price of $0.50 per Share on or before January 2, 2025, being 46 months following the date of closing of the transaction. In connection with the transaction, the company paid the Agents CAD 651,084.20 in commissions and advisory fees and issued1,441,580 special broker warrants to the agents. Each special broker warrant is automatically exercisable into one broker warrant for no additional payment on the automatic exercise date. Each Broker Warrant will be exercisable into one Unit, subject to adjustment, at CAD 0.365 per unit for a period of 24 months from the closing of the transaction. Each Unit is comprised of one Share and one-half of one Warrant. All securities issued in connection with the transaction are subject to a statutory hold period of four months plus a day in accordance with applicable securities legislation ending on July 3, 2021. Is New 90 Day High Low • Feb 09
New 90-day high: CA$0.46 The company is up 296% from its price of CA$0.12 on 10 November 2020. The Canadian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is up 80% over the same period. Announcement • Jan 22
Hollister Biosciences Inc. announced that it expects to receive CAD 5.000135 million in funding Hollister Biosciences Inc. (CNSX:HOLL) announced a best efforts private placement of 13,699,000 special warrants at a price of CAD 0.365 per warrant for gross proceeds of CAD 5,000,135 on January 20, 2021. Each special warrant will be automatically exercisable into units of the company, for no additional consideration, on the earlier of the date that is 3 days following the date on which the company obtains a receipt from the applicable securities regulatory authorities for prospectus and the date that is four months and one day from the date of closing. Each unit consists of one common share and one-half of one share purchase warrant of the company. Each warrant is exercisable at a price of CAD 0.50 per share for a period of 46 months from the date of closing. The company has granted the agents an option to offer for sale up to an additional 15% of the special warrants, exercisable in whole or in part at any time for a period of up to 48 hours prior to the closing date. All securities to be issued will be subject to a four month hold period. The transaction is subject to all required regulatory approvals. Is New 90 Day High Low • Jan 09
New 90-day high: CA$0.33 The company is up 230% from its price of CA$0.10 on 09 October 2020. The Canadian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is up 59% over the same period. Announcement • Dec 23
Hollister Biosciences Inc.'s Direct to Consumer Cannabis Delivery Platform, Dreamy Delivery Launches Depot in Sacramento, California Hollister Biosciences Inc. announced the launch of its 2nd fulfillment depot for its direct-to-consumer cannabis delivery platform, Dreamy Delivery. The Company soft launched Dreamy Delivery to friends and family in the San Francisco Bay Area of Northern California, to ensure a seamless customer experience in early Fourth Quarter of 2020. The Company has expanded the Platform, with Dreamy now successfully delivering to legal cannabis consumers in the San Francisco Bay Area of Northern California and now Sacramento, California. The Company hopes to launch Dreamy in the Central Coast of California by early First Quarter of 2021 with the ultimate goal of delivering Cannabis statewide. Announcement • Dec 18
Hollister Biosciences Inc. Signs Exclusive Agreement with Easyriders to Design, Manufacture and Produce A National Cannabis Product Line Hollister Biosciences Inc. Signs Exclusive Agreement with Easyriders to Design, Manufacture and Produce a National Cannabis Product Line. The Company feels the market potential for these products is significant, but so is the cultural significance considering the two companies involved. The terms of the deal are; 2-year exclusive agreement on all cannabis products in the US with an 80:20 net revenue split in favour of Hollister with options to renew for subsequent terms. Announcement • Dec 16
Allied Corp. Announces Distribution Deal with Hollister Biosciences Allied Corp. announced a distribution deal with Hollister Biosciences. Under the arrangement, Allied's Tactical ReliefTM branded products will be sold in licensed dispensaries across California. Through their extensive distribution network, Hollister's other brands have brought in excess of $40 million revenue between January and December 2020. Is New 90 Day High Low • Dec 11
New 90-day high: CA$0.23 The company is up 114% from its price of CA$0.10 on 11 September 2020. The Canadian market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is up 49% over the same period. Announcement • Nov 11
Hollister Biosciences Inc. Launches Direct to Consumer Cannabis Delivery Platform, Dreamy Delivery Hollister Biosciences Inc. announced the launch of its direct to consumer cannabis delivery platform, Dreamy Delivery. The company soft launched Dreamy Delivery to friends and family in the San Francisco Bay Area of Northern California, to ensure a seamless customer experience in early Fourth Quarter of 2020. The Company has expanded the Platform, with Dreamy now successfully delivering to legal cannabis consumers in the Bay Area. The Company hopes to launch Dreamy in Sacramento and the Central Coast of California by late Fourth Quarter of 2020 with the ultimate goal of delivering Cannabis statewide. Announcement • Aug 11
Hollister Biosciences Inc. announced that it has received CAD 1.5 million in funding On august 10, 2020, Hollister Biosciences Inc. (CNSX:HOLL) closed the transaction. Each warrant entitles the holder to purchase additional common share of the company at CAD 0.10 per share until August 10, 2022. The company has aggregate of CAD 108,201.26 in cash and compensation options to acquire up to a total of 1,272,959 unit at a price of CAD 0.085 per unit on or before August 10, 2022 as finders fees. Each finders' unit will consist of one share and one non-transferable share purchase warrant, exercisable at a price of CAD 0.10 per share on or before August 10, 2022. All securities issued in connection with the Offering are subject to a statutory hold period of four months and one day ending on December 11, 2020. Announcement • Jul 31
Hollister Biosciences Inc. (CNSX:HOLL) completed the acquisition of Alphamind Brands for CAD 0.81 million. Hollister Biosciences Inc. (CNSX:HOLL) entered into a letter of intent to acquire Alphamind Brands for approximately CAD 0.57 million on March 9, 2020. Hollister Biosciences Inc. (CNSX:HOLL) entered into a definitive agreement to acquire Alphamind Brands on April 22, 2020. As consideration, Hollister Biosciences Inc. shall issue 6 million in common stock. In connection with the transaction, Hollister Biosciences Inc. will not be assuming any long-term debt and there is no change in management, or the Board of Directors of Hollister Biosciences Inc. The acquisition is subject to due diligence and the receipt by Hollister of any necessary corporate and regulatory approval.
Hollister Biosciences Inc. (CNSX:HOLL) completed the acquisition of Alphamind Brands for CAD 0.81 million on April 30, 2020. Under the terms of the transaction, Hollister Biosciences issued 4.2 million of its common shares on closing and an additional 1.8 million earn-out shares will be issued pro rata to the former shareholders of AlphaMind on the earlier of AlphaMind meeting certain milestones or December 31, 2021. The payment shares are subject to certain voluntary hold periods. Announcement • Jul 18
Hollister Biosciences Inc. Auditor Raises 'Going Concern' Doubt Hollister Biosciences Inc. filed its Annual on Jul 14, 2020 for the period ending Dec 31, 2019. In this report its auditor, Davidson & Company, gave an unqualified opinion expressing doubt that the company can continue as a going concern. 
